A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute ...

Quetzal Therapeutics, a biopharmaceutical company specializing in developing transformative treatments for rare diseases, announced the initiation of a pivotal Phase III clinical trial of QTX-2101, an ...

Cortes discussed the evolution of chronic myeloid leukemia treatment and emerging strategies aimed at improving outcomes and quality of life. Dr. Jorge E. Cortes sat down with CURE to discuss the ...

ALL is the most common childhood cancer, and cases are rising. Find out why this trend is paired with a remarkable 90% survival rate, and what public health action is needed next.

Scientists have uncovered how leukemia cells manage to escape one of the most commonly used treatments. Over time, these ...

TIBSOVO is a targeted therapy that works against an abnormal protein created by a mutation in the IDH1 gene. This abnormal ...

A specialized treatment in a US children's hospital could save her life. But her family has already spent everything they had ...

Graft-versus-host disease (GVHD) is a potential post-transplant complication. Here’s how one patient and his wife are ...

Schlossberg, 34, wrote in a heart-wrenching essay for the New Yorker published Nov. 22 she learned she had acute myeloid ...

Choi Sun-ah, a professor of pediatrics at Ewha Womans University Mokdong Hospital, published a study in collaboration with Dr ...